Offstream
news

Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
2021-08-12

The Ministry of Health approves the emergency use of the Sinopharm BBIBP-CorV vaccine for children between the ages of 3 and 17 years old in the UAE.
2021-08-2

President Rodrigo Duterte receives his first dose of the Sinopharm BBIBP-CorV vaccine.
2021-05-3

The Indonesian Food and Drug Authority grants an emergency use authorization for the Sinopharm BBIBP-CorV vaccine, where the vaccine will be used as part of a mutual vaccination scheme.
2021-04-30

Sri Lanka receives 600,000 doses of the Sinopharm BBIBP-CorV vaccine from China. Vaccination of Chinese nationals could commence first as the Medicines Regulatory Authority says that the vaccination of Sri Lankans will begin after a study by a committee of experts.
2021-03-31

Pakistan Prime Minister Imran Khan receives his first dose of the Sinopharm BBIBP-CorV vaccine.
2021-03-18

Venezuela receives 500,000 doses of the Sinopharm BBIBP-CorV vaccine donated by China.
2021-03-2

Prime Minister Viktor Orbán receives the first dose of the Sinopharm BBIBP-CorV vaccine.
2021-02-28

Bahrain's National Health Regulatory Authority approves the registration of the BBIBP-CorV vaccine developed by Sinopharm after Phase III clinical trials results showed an 86% efficacy rate.
2020-12-13

Sinopharm began Phase III trials in Peru starting with two dozen people, with the goal to vaccinate 6,000 people between the ages of 18 and 75. So far, Sinopharm has given 30,000 doses to volunteers and another 10,000 participants have received double doses in Bahrain and the United Arab Emirates, with additional trials planned for Morocco and Argentina.
2020-09-10